NCT00002157View on ClinicalTrials.gov

Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV InfectionsHIV Wasting Syndrome
Interventions
DRUG

Thalidomide

Trial Locations (1)

07059

Celgene Corp, Warren Township

Sponsors
All Listed Sponsors
lead

Celgene Corporation

INDUSTRY

NCT00002157 - Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome | Biotech Hunter | Biotech Hunter